PETALING JAYA: Pharmaniaga Bhd
expects to grow the revenue contribution from its Indonesian operations by 17% to 18% this year.
For the financial year ended December 31, 2017, the group registered a total revenue of RM2.3bil, of which 32% or RM736mil was from its Indonesian operations.
Speaking at the group’s annual general meeting today, Pharmaniaga managing director Datuk Farshila Emran said: “We are confident that the Indonesian operations will continue to do well, riding on the population growth, increasing living affluence, and rising demand for better healthcare products.”
The group has allocated an estimated RM75mil for this year’s capital expenditure, which has been earmarked for the upgrading of its machineries and equipment in Indonesia, as well as warehousing facilities in Malaysia.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
